Loading...
Chemical structure of PCO371

GC32415

PCO371

Also known as 1-[3,5-dimethyl-4-[2-[[4-oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-8-yl]sulfonyl]ethyl]phenyl]-5,5-dimethylimidazolidine-2,4-dione

PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1), with no effect on PTH type 2 receptor

ChemicalCAS1613373-33-3MW635.65FormulaC29H32F3N5O6S
CAS number
1613373-33-3
Molecular weight
635.65
Formula
C29H32F3N5O6S
Solubility
DMSO： 125 mg/mL (196·65 mM)
InChIKey
LDZJFVOUPUFOHX-UHFFFAOYSA-N
Catalogue number
GC32415
Brand
GLPBIO
Computed properties PubChem CID 76283707 · XLogP 3.7 · TPSA 146 Ų · H-bond donors 2
XLogP
3.7
TPSA
146 Ų
H-bond donors
2
H-bond acceptors
11
Rotatable bonds
7
Heavy atoms
44

SMILES CC1=CC(=CC(=C1CCS(=O)(=O)N2CCC3(CC2)C(=O)NC(=N3)C4=CC=C(C=C4)OC(F)(F)F)C)N5C(=O)NC(=O)C5(C)C

Computed descriptors from PubChem (CID 76283707), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.